Novel quinoline derivatives was designed as anticancer iron chelators. Structurally they combine active moieties of known quinoline and thiosemicarbazone bioeffectors. For the synthetic part of study we applied microvawe assisted techniques MAOS. Resulted compounds exhibited interesting anticancer activities against HCT116 cancer cells.
interesting herbicidal activities [6, [8] [9] [10] [11] [12] [13] . Some investigated compounds also showed antineoplastic activity [14] . This encouraged us to exploit the usability of quinoline scaffold in anticancer iron chelators. We aimed to functionalization of simple quinoline moiety with thiosemicarbaides, key part of another important bioeffectors and highly potential iron chelators: thiosemicarbazones.
This class of chelators was one of the first groups of ligands to be characterised for potent antitumour activity [15] [16] [17] [18] . Particular structure of these class of compounds i.e. vicinity of sulfur and nitrogen atoms makes them valuable chelators for iron and other similar metal cations as Cu 2+ , Co 2+ , Mn 2+ , Zn 2+ [16, [19] [20] [21] [22] .
Triapine ® Dp44mT There are two possible way of exhibition of anticancer potency through blocking of Ribonucleotide reductase (RR) [15] [16] [17] [18] or by specific red-ox activity [23] . Especially the redox activity of Fe-complexes should be emphasized. Reduction of complex of Fe 3+ -thiosemicarbazone lead to generation of reactive oxygen species (ROS) whose may be responsible also for inhibition of RR as they are able to quench the tyrosyl radical of the R2 subunit of RR [24] . This was proven by Shiao et al. who shown that Fe-Triapine complex is better inhibitor of RR than chelator alone [25] .
Nevertheless many potential mechanisms of action of thiosemicarbazones should be highlighted as triggers for the designing of new drugs.
Results and discussion
In our approach we combined two moieties of known potency to design new anticancer agents I and II (Fig. 2. ). For synthetic part we have applied our experience in microwave assisted chemistry carrying most of the steps in this efficient and green technique [26] . Microwave heating was especially useful in synthesis of structures Ia and Ib, where facilitated 3 out of 4 steps (with preparation of polyphosphoric acid). Yields of main product was good (above 80%) and the purity satisfying even without column chromatography.
Discovery microwave reactor from CEM was used for all synthesis. Structure of all new compounds was confirmed with NMR, MS and IR techniques. For purification we used Sepacore preparative chromatography from Buchi.
The anti-proliferative activity of the synthesized compounds were assessed by the MTT assay against the HCT116 (human colon carcinoma) cell line by the MTS assay. Cells obtained from the ATCC were grown as monolayer cultures in 75 cm2 flasks (Nunc) in Dulbecco's modified Eagle's medium supplemented with 12% foetal bovine serum (Gibco-BRL), 100 µg/mL of gentamycin, 100 µg/mL of streptomycin and 100 IU/mL of crystalline penicillin (Polfa). Cells were cultured under standard conditions at 37°C, in a humidified atmosphere at 5% CO 2 .
Twenty four hours before addition of the tested compounds, the cells were seeded in 96-well 
4-Hydroxyquinolin-2(1H)-one

General procedure for synthesis Ia and Ib
The appropriate quinoline derivative was dissolved in ethanol, then thiosemicarbazide was added and microwave tube was closed using special capper and heated for 8 minutes in 82 °C. Pressure and temperature was controlled. The crude product was purified by simple crystallization using ethanol and diethyl ether. Further studies on structure optimization as well as elucidation of mechanism of action will be performed. Synthetic procedure presented here is time and cost efficient and allows obtaining relatively wide group of compounds for biological tests. Additional assays as redox potential measurement of Fe-complexes and prolonged cytotoxicity as clonogenity are currently running. We hope these studies will open new promising field of research.
